Coloplast As ADR (CLPBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Sales | 4,128,139 | 3,930,162 | 3,513,300 | 3,292,018 | 3,121,758 |
| Cost of Goods | 1,322,385 | 1,273,849 | 1,171,865 | 1,027,890 | 982,359 |
| Gross Profit | 2,805,754 | 2,656,313 | 2,341,435 | 2,264,128 | 2,139,399 |
| Operating Expenses | 1,739,671 | 1,592,834 | 1,371,339 | 1,326,212 | 1,150,650 |
| Operating Income | 1,066,468 | 1,064,328 | 970,961 | 938,806 | 989,109 |
| Interest Expense | 170,463 | 159,940 | 134,366 | 62,840 | 9,481 |
| Other Income | 15,847 | 25,445 | 27,389 | 17,350 | 22,016 |
| Pre-tax Income | 911,852 | 929,833 | 863,985 | 893,317 | 1,001,643 |
| Income Tax | 373,360 | 195,272 | 178,103 | 207,182 | 226,266 |
| Net Income Continuous | 538,492 | 734,561 | 685,882 | 686,135 | 775,378 |
| Net Income | $538,492 | $734,561 | $685,882 | $686,135 | $775,378 |
| EPS Basic Total Ops | 0.24 | 0.33 | 0.32 | 0.32 | 0.36 |
| EPS Basic Continuous Ops | 0.24 | 0.33 | 0.32 | 0.32 | 0.36 |
| EPS Diluted Total Ops | 0.24 | 0.33 | 0.32 | 0.32 | 0.36 |
| EPS Diluted Continuous Ops | 0.24 | 0.33 | 0.32 | 0.32 | 0.36 |
| EPS Diluted Before Non-Recurring Items | 0.26 | 0.32 | 0.33 | 0.34 | 0.37 |
| EBITDA(a) | $1,281,657 | $1,251,894 | $1,124,256 | $1,074,400 | $1,116,383 |